Jenny E Ozga
Overview
Explore the profile of Jenny E Ozga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sargent J, Lauten K, Edwards K, Tanski S, MacKenzie T, Paulin L, et al.
EClinicalMedicine
. 2025 Feb;
79:102951.
PMID: 39968205
Background: Substitution of noncombustible tobacco products for cigarettes could improve respiratory symptoms. We hypothesized that complete cigarette-to-e-cigarette switching would improve respiratory symptoms compared to continued smoking. Methods: Longitudinal analysis of...
2.
Ozga J, Bold K, Giovenco D, Villanti A, Unger J, Leventhal A, et al.
Tob Control
. 2025 Feb;
PMID: 39947699
No abstract available.
3.
Shi R, Khayat A, Lee J, Garrison K, Jebai R, Wackowski O, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2459188.
PMID: 39937476
Importance: The US has implemented several regulatory measures to govern the sale and marketing of electronic nicotine delivery systems (ENDS). A nicotine warning statement requirement became effective in September 2018,...
4.
Burns A, Steinberg A, Sargent J, Ozga J, Tang Z, Stanton C, et al.
Respir Res
. 2025 Feb;
26(1):49.
PMID: 39920672
Background: Prior research has linked e-cigarette use with chronic obstructive pulmonary disease (COPD). We examined the relationship between e-cigarette use and COPD prevalence in older adults with varying cigarette use...
5.
Sharma A, Belton A, Ozga J, Ling P, Hrywna M, Ross J, et al.
Tob Control
. 2024 Nov;
PMID: 39613332
Introduction: Although the popularity of oral nicotine products (ONPs) such as ZYN and On! is growing globally, there is limited research on their marketing and advertising. This report describes recent...
6.
Sargent J, Ozga J, Stanton C, Tang Z, Paulin L
Res Sq
. 2024 Nov;
PMID: 39606494
Background: Cigarette smoking is an established risk factor for lower health-related quality of life (HRQOL). Studies to date have not used comprehensive measures of tobacco exposures across the life course....
7.
Ozga J, Shuter J, Chander G, Graham A, Kim R, Stanton C
Drug Alcohol Depend Rep
. 2024 Oct;
9:100200.
PMID: 39473544
[This corrects the article DOI: 10.1016/j.dadr.2023.100172.].
8.
Kim M, Vassey J, Li D, Galimov A, Han E, Kirkpatrick M, et al.
J Med Internet Res
. 2024 Oct;
26:e53938.
PMID: 39446431
Background: Understanding public opinions about emerging tobacco products is important to inform future interventions and regulatory decisions. Heated tobacco products (HTPs) are an emerging tobacco product category promoted by the...
9.
Ozga J, Sargent J, Steinberg A, Tang Z, Stanton C, Paulin L
Chronic Obstr Pulm Dis
. 2024 Oct;
11(6):549-557.
PMID: 39413254
Introduction: A recent study found that the prevalence of chronic obstructive pulmonary disease (COPD) is significantly higher among adults who began smoking cigarettes before (versus after) 15 years of age,...
10.
Rastogi K, Czaplicki L, Spindle T, Moran M, Ozga J, Stanton C, et al.
Tob Control
. 2024 Oct;
PMID: 39366757
No abstract available.